TheraVectys Is Said to Mull Hong Kong IPO in Rare Move for Non-Chinese Biotech Firm

TheraVectys SA is considering an initial public offering in Hong Kong, according to people familiar with the matter, a rare move for a non-Chinese biotech firm despite a wave of listings in the Asian financial hub.